摘要
Background: Remote ischemic preconditioning (RIPC) protects against ischemic stroke, yet its mechanisms remain unknown. Here we investigate whether RIPC modulates the ubiquitin-specific protease 24 (USP24) -mediated suppression of both ferroptosis and inflammation.
Methods: Transient middle cerebral artery occlusion (MCAO) was established in C57BL/6 mice. Pharmacological manipulation was performed to modulate ferroptosis (Erastin, Ferrostatin-1) and a selective USP24 inhibitor (EOAI3402143). Inflammatory cytokines were examined by qRT-PCR in the brain, blood, spleen and colon; ferroptosis-related genes and indices were assessed in brain tissue by western blotting, immunofluorescence, and biochemical assays.
Results: RIPC conferred neuroprotection at 24 h post-reperfusion, as evidenced by reduced infarct size, improved neurological scores, and decreased foot fault rate, alongside alleviation of ferroptosis and mitochondrial damage detected by transcriptomic profiling and transmission electron microscopy. Ferroptosis activator Erastin reversed RIPC's neuroprotection, whereas the inhibitor Ferrostatin-1 enhanced it. RIPC attenuated inflammation in the brain, spleen, blood, and colon. Among the brain inflammatory related differentially expressed genes (DEGs), USP24 was downregulated after MCAO and restored by RIPC. USP24 inhibitor EOAI3402143 abolished RIPC's neuroprotective effects, and inhibit the brain and systemic inflammatory response. In addition, EOAI3402143 reversed RIPC-induced downregulation of Fe²⁺, MDA and long-chain acyl-CoA synthetase 4 (ACSL4), and upregulation of GSH/GSSG, SOD glutathione peroxidase 4 (GPX4).
Conclusion: RIPC confers neuroprotection against ischemic stroke by upregulating USP24, which in turn suppresses ferroptosis and neuroinflammation.
